All lobbying filings
Akin Gump Strauss Hauer & Feld
Akin Gump Strauss Hauer & Feld filed a Q3 report for Pharmaceutical Research and Manufacturers of America on October 20, 2026, reporting $120,000 in lobbying income.
Lobbying for Pharmaceutical Research and Manufacturers of America · Trade association.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$120,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Government bodies contacted
2
Lobbying activity
3
Issues related to patent reform legislation. Issues related to H.R. 3160/S. 1553 - The PREVAIL Act.
Issues related to budget reconciliation; Issues related to Most Favored Nation pricing proposals; Issues related to Senate Democrat member request for information related to drug pricing.
Issues related to IP protection; Issues related to market access issues; Issues related to PhRMA 232.